See More Hear More Watch More Hear More Get on iTunes
TIME's The Brief TIMEnewsbrief

Eli Lilly To Abandon Cardiovascular Disease Drug

Evacetrapib was the company’s only cardiovascular-focused drug in the late-stage pipeline. more info: http://time.com/4070293/eli-lilly-evacetrapib-phase-3/ #FullNewsAudioAvailable

UP NEXT

More from